HH1 (2003) | Baseline (n=94) | 6-weeks (n=86) | 6- months (n=97) | Chi-square Valuea(p-value) | ||
---|---|---|---|---|---|---|
Screening Rate | AUDIT-C | n/a | 94.7% | 95.3% | 85.6% | 7.393 (p=.025) |
SASQ | --- | -- | 71.4% | 45.4% | 13.123 (p<.001) | |
AUDIT-C and/or SASQ | n/a | 94.7% | 97.6% | 90.6% | 3.991 (p=.136) | |
Patients screened | n=3014 | (n=91) | (n=84) | (n=92) | ||
Positive Rate | AUDIT-C | 8.0% | 4.4% | 14.3% | 14.1% | 5.962 (p=.051) |
(% of Screened) | SASQ | ------- | -- | 22.4% | 13.6% | 1.326 (p=.250) |
AUDIT-C and/or SASQ | 8.0% | 4.4% | 22.9% | 18.8% | 13.004 (p=.002) | |
Screen positives | n=241 | (n=4) | (n=21) | (n=18) | ||
Intervention Rate (% of Screen Positives) | 47.7% | 25.0% | 52.4% | 61.1% | 1.736 (p=.420) |